A Phase I Single Center, Double-Blind, Placebo-Controlled, Multiple Dose-Ascending Study to Evaluate the Pharmacokinetics and Tolerability of CTP-730 Immediate Release at Steady State in Healthy Adults

Trial Profile

A Phase I Single Center, Double-Blind, Placebo-Controlled, Multiple Dose-Ascending Study to Evaluate the Pharmacokinetics and Tolerability of CTP-730 Immediate Release at Steady State in Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs CTP 730 (Primary)
  • Indications Cancer; Inflammation
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Concert Pharmaceuticals
  • Most Recent Events

    • 30 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 28 May 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
    • 31 Mar 2015 Status changed from planning to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top